nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—IMPA1—hematopoietic system—stomach cancer	0.0163	0.0793	CbGeAlD
Lithium—GSK3B—hematopoietic system—stomach cancer	0.012	0.0584	CbGeAlD
Lithium—IMPA1—lymphoid tissue—stomach cancer	0.0115	0.0558	CbGeAlD
Lithium—GSK3B—epithelium—stomach cancer	0.0109	0.0533	CbGeAlD
Lithium—GSK3B—smooth muscle tissue—stomach cancer	0.0105	0.0514	CbGeAlD
Lithium—IMPA2—pancreas—stomach cancer	0.00994	0.0484	CbGeAlD
Lithium—IMPA1—endocrine gland—stomach cancer	0.00935	0.0455	CbGeAlD
Lithium—GSK3A—smooth muscle tissue—stomach cancer	0.00917	0.0447	CbGeAlD
Lithium—IMPA2—digestive system—stomach cancer	0.00849	0.0414	CbGeAlD
Lithium—GSK3A—pancreas—stomach cancer	0.00848	0.0413	CbGeAlD
Lithium—GSK3B—lymphoid tissue—stomach cancer	0.00843	0.0411	CbGeAlD
Lithium—IMPA1—liver—stomach cancer	0.00843	0.0411	CbGeAlD
Lithium—GSK3B—digestive system—stomach cancer	0.00833	0.0406	CbGeAlD
Lithium—IMPA2—bone marrow—stomach cancer	0.00783	0.0381	CbGeAlD
Lithium—GSK3A—digestive system—stomach cancer	0.00724	0.0353	CbGeAlD
Lithium—GRIA3—liver—stomach cancer	0.00717	0.0349	CbGeAlD
Lithium—GSK3B—endocrine gland—stomach cancer	0.00688	0.0335	CbGeAlD
Lithium—GSK3A—bone marrow—stomach cancer	0.00668	0.0325	CbGeAlD
Lithium—IMPA2—liver—stomach cancer	0.00633	0.0308	CbGeAlD
Lithium—GSK3B—liver—stomach cancer	0.00621	0.0302	CbGeAlD
Lithium—GSK3A—endocrine gland—stomach cancer	0.00598	0.0292	CbGeAlD
Lithium—GSK3A—liver—stomach cancer	0.0054	0.0263	CbGeAlD
Lithium—IMPA2—lymph node—stomach cancer	0.00485	0.0236	CbGeAlD
Lithium—GSK3B—lymph node—stomach cancer	0.00476	0.0232	CbGeAlD
Lithium—GSK3A—lymph node—stomach cancer	0.00414	0.0202	CbGeAlD
Lithium—Arrhythmia—Fluorouracil—stomach cancer	0.000631	0.00244	CcSEcCtD
Lithium—Muscular weakness—Capecitabine—stomach cancer	0.00063	0.00243	CcSEcCtD
Lithium—Coma—Epirubicin—stomach cancer	0.000626	0.00242	CcSEcCtD
Lithium—Alopecia—Fluorouracil—stomach cancer	0.000624	0.00241	CcSEcCtD
Lithium—Salivary hypersecretion—Doxorubicin—stomach cancer	0.000616	0.00238	CcSEcCtD
Lithium—Polyuria—Methotrexate—stomach cancer	0.000605	0.00234	CcSEcCtD
Lithium—Hypertonia—Epirubicin—stomach cancer	0.000601	0.00232	CcSEcCtD
Lithium—Weight increased—Docetaxel—stomach cancer	0.00058	0.00224	CcSEcCtD
Lithium—Vision blurred—Fluorouracil—stomach cancer	0.00058	0.00224	CcSEcCtD
Lithium—Coma—Doxorubicin—stomach cancer	0.000579	0.00224	CcSEcCtD
Lithium—Vertigo—Irinotecan—stomach cancer	0.000577	0.00223	CcSEcCtD
Lithium—Weight decreased—Docetaxel—stomach cancer	0.000577	0.00223	CcSEcCtD
Lithium—Syncope—Irinotecan—stomach cancer	0.000576	0.00222	CcSEcCtD
Lithium—Loss of consciousness—Irinotecan—stomach cancer	0.000565	0.00218	CcSEcCtD
Lithium—Weight increased—Capecitabine—stomach cancer	0.000561	0.00217	CcSEcCtD
Lithium—Weight decreased—Capecitabine—stomach cancer	0.000558	0.00215	CcSEcCtD
Lithium—Hyperglycaemia—Capecitabine—stomach cancer	0.000557	0.00215	CcSEcCtD
Lithium—Hypertonia—Doxorubicin—stomach cancer	0.000556	0.00214	CcSEcCtD
Lithium—Lethargy—Methotrexate—stomach cancer	0.000542	0.00209	CcSEcCtD
Lithium—Discomfort—Irinotecan—stomach cancer	0.00054	0.00209	CcSEcCtD
Lithium—Convulsion—Fluorouracil—stomach cancer	0.000533	0.00206	CcSEcCtD
Lithium—Confusional state—Irinotecan—stomach cancer	0.000529	0.00204	CcSEcCtD
Lithium—Oedema—Irinotecan—stomach cancer	0.000524	0.00202	CcSEcCtD
Lithium—Discomfort—Fluorouracil—stomach cancer	0.000517	0.002	CcSEcCtD
Lithium—Shock—Irinotecan—stomach cancer	0.000516	0.00199	CcSEcCtD
Lithium—Lethargy—Epirubicin—stomach cancer	0.000507	0.00196	CcSEcCtD
Lithium—Confusional state—Fluorouracil—stomach cancer	0.000506	0.00195	CcSEcCtD
Lithium—Bradycardia—Capecitabine—stomach cancer	0.000503	0.00194	CcSEcCtD
Lithium—Oedema—Fluorouracil—stomach cancer	0.000502	0.00194	CcSEcCtD
Lithium—Anorexia—Irinotecan—stomach cancer	0.0005	0.00193	CcSEcCtD
Lithium—Ataxia—Methotrexate—stomach cancer	0.0005	0.00193	CcSEcCtD
Lithium—Hypotension—Irinotecan—stomach cancer	0.00049	0.00189	CcSEcCtD
Lithium—Anorexia—Fluorouracil—stomach cancer	0.000479	0.00185	CcSEcCtD
Lithium—Lethargy—Doxorubicin—stomach cancer	0.00047	0.00181	CcSEcCtD
Lithium—Hypotension—Fluorouracil—stomach cancer	0.000469	0.00181	CcSEcCtD
Lithium—Ataxia—Epirubicin—stomach cancer	0.000468	0.0018	CcSEcCtD
Lithium—Somnolence—Irinotecan—stomach cancer	0.000466	0.0018	CcSEcCtD
Lithium—Dehydration—Epirubicin—stomach cancer	0.000462	0.00178	CcSEcCtD
Lithium—Dyspepsia—Irinotecan—stomach cancer	0.000461	0.00178	CcSEcCtD
Lithium—Tinnitus—Capecitabine—stomach cancer	0.00046	0.00178	CcSEcCtD
Lithium—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000457	0.00177	CcSEcCtD
Lithium—Dry skin—Epirubicin—stomach cancer	0.000456	0.00176	CcSEcCtD
Lithium—Decreased appetite—Irinotecan—stomach cancer	0.000456	0.00176	CcSEcCtD
Lithium—Arrhythmia—Docetaxel—stomach cancer	0.000456	0.00176	CcSEcCtD
Lithium—Fatigue—Irinotecan—stomach cancer	0.000452	0.00174	CcSEcCtD
Lithium—Alopecia—Docetaxel—stomach cancer	0.000451	0.00174	CcSEcCtD
Lithium—Somnolence—Fluorouracil—stomach cancer	0.000446	0.00172	CcSEcCtD
Lithium—Dyspepsia—Fluorouracil—stomach cancer	0.000442	0.00171	CcSEcCtD
Lithium—Arrhythmia—Capecitabine—stomach cancer	0.000441	0.0017	CcSEcCtD
Lithium—Gastritis—Epirubicin—stomach cancer	0.00044	0.0017	CcSEcCtD
Lithium—Muscular weakness—Epirubicin—stomach cancer	0.000439	0.00169	CcSEcCtD
Lithium—Decreased appetite—Fluorouracil—stomach cancer	0.000436	0.00168	CcSEcCtD
Lithium—Alopecia—Capecitabine—stomach cancer	0.000436	0.00168	CcSEcCtD
Lithium—Dysgeusia—Docetaxel—stomach cancer	0.000435	0.00168	CcSEcCtD
Lithium—Ataxia—Doxorubicin—stomach cancer	0.000433	0.00167	CcSEcCtD
Lithium—Feeling abnormal—Irinotecan—stomach cancer	0.000432	0.00167	CcSEcCtD
Lithium—Gastrointestinal pain—Irinotecan—stomach cancer	0.000429	0.00165	CcSEcCtD
Lithium—Dehydration—Doxorubicin—stomach cancer	0.000428	0.00165	CcSEcCtD
Lithium—Flatulence—Capecitabine—stomach cancer	0.000424	0.00163	CcSEcCtD
Lithium—Erectile dysfunction—Methotrexate—stomach cancer	0.000423	0.00163	CcSEcCtD
Lithium—Dry skin—Doxorubicin—stomach cancer	0.000422	0.00163	CcSEcCtD
Lithium—Dysgeusia—Capecitabine—stomach cancer	0.000421	0.00162	CcSEcCtD
Lithium—Abdominal pain—Irinotecan—stomach cancer	0.000414	0.0016	CcSEcCtD
Lithium—Body temperature increased—Irinotecan—stomach cancer	0.000414	0.0016	CcSEcCtD
Lithium—Feeling abnormal—Fluorouracil—stomach cancer	0.000414	0.0016	CcSEcCtD
Lithium—Drowsiness—Methotrexate—stomach cancer	0.00041	0.00158	CcSEcCtD
Lithium—Gastritis—Doxorubicin—stomach cancer	0.000407	0.00157	CcSEcCtD
Lithium—Muscular weakness—Doxorubicin—stomach cancer	0.000406	0.00157	CcSEcCtD
Lithium—Vision blurred—Capecitabine—stomach cancer	0.000405	0.00156	CcSEcCtD
Lithium—Tremor—Capecitabine—stomach cancer	0.000403	0.00155	CcSEcCtD
Lithium—Syncope—Docetaxel—stomach cancer	0.000398	0.00154	CcSEcCtD
Lithium—Body temperature increased—Fluorouracil—stomach cancer	0.000397	0.00153	CcSEcCtD
Lithium—Weight increased—Epirubicin—stomach cancer	0.000391	0.00151	CcSEcCtD
Lithium—Loss of consciousness—Docetaxel—stomach cancer	0.00039	0.00151	CcSEcCtD
Lithium—Weight decreased—Epirubicin—stomach cancer	0.000389	0.0015	CcSEcCtD
Lithium—Hyperglycaemia—Epirubicin—stomach cancer	0.000388	0.0015	CcSEcCtD
Lithium—Vertigo—Capecitabine—stomach cancer	0.000386	0.00149	CcSEcCtD
Lithium—Syncope—Capecitabine—stomach cancer	0.000386	0.00149	CcSEcCtD
Lithium—Convulsion—Docetaxel—stomach cancer	0.000385	0.00148	CcSEcCtD
Lithium—Drowsiness—Epirubicin—stomach cancer	0.000383	0.00148	CcSEcCtD
Lithium—Arthralgia—Docetaxel—stomach cancer	0.000378	0.00146	CcSEcCtD
Lithium—Loss of consciousness—Capecitabine—stomach cancer	0.000378	0.00146	CcSEcCtD
Lithium—Asthenia—Irinotecan—stomach cancer	0.000376	0.00145	CcSEcCtD
Lithium—Dry mouth—Docetaxel—stomach cancer	0.00037	0.00143	CcSEcCtD
Lithium—Arthralgia—Capecitabine—stomach cancer	0.000366	0.00141	CcSEcCtD
Lithium—Confusional state—Docetaxel—stomach cancer	0.000365	0.00141	CcSEcCtD
Lithium—Oedema—Docetaxel—stomach cancer	0.000362	0.0014	CcSEcCtD
Lithium—Weight increased—Doxorubicin—stomach cancer	0.000362	0.0014	CcSEcCtD
Lithium—Discomfort—Capecitabine—stomach cancer	0.000362	0.0014	CcSEcCtD
Lithium—Weight decreased—Doxorubicin—stomach cancer	0.00036	0.00139	CcSEcCtD
Lithium—Hyperglycaemia—Doxorubicin—stomach cancer	0.000359	0.00138	CcSEcCtD
Lithium—Diarrhoea—Irinotecan—stomach cancer	0.000359	0.00138	CcSEcCtD
Lithium—Dry mouth—Capecitabine—stomach cancer	0.000358	0.00138	CcSEcCtD
Lithium—Shock—Docetaxel—stomach cancer	0.000357	0.00138	CcSEcCtD
Lithium—Drowsiness—Doxorubicin—stomach cancer	0.000355	0.00137	CcSEcCtD
Lithium—Confusional state—Capecitabine—stomach cancer	0.000354	0.00137	CcSEcCtD
Lithium—Oedema—Capecitabine—stomach cancer	0.000351	0.00135	CcSEcCtD
Lithium—Bradycardia—Epirubicin—stomach cancer	0.00035	0.00135	CcSEcCtD
Lithium—Dizziness—Irinotecan—stomach cancer	0.000347	0.00134	CcSEcCtD
Lithium—Anorexia—Docetaxel—stomach cancer	0.000345	0.00133	CcSEcCtD
Lithium—Shock—Capecitabine—stomach cancer	0.000345	0.00133	CcSEcCtD
Lithium—Diarrhoea—Fluorouracil—stomach cancer	0.000344	0.00133	CcSEcCtD
Lithium—Tinnitus—Methotrexate—stomach cancer	0.000343	0.00132	CcSEcCtD
Lithium—Hypotension—Docetaxel—stomach cancer	0.000339	0.00131	CcSEcCtD
Lithium—Anorexia—Capecitabine—stomach cancer	0.000334	0.00129	CcSEcCtD
Lithium—Vomiting—Irinotecan—stomach cancer	0.000333	0.00129	CcSEcCtD
Lithium—Dizziness—Fluorouracil—stomach cancer	0.000332	0.00128	CcSEcCtD
Lithium—Rash—Irinotecan—stomach cancer	0.000331	0.00128	CcSEcCtD
Lithium—Dermatitis—Irinotecan—stomach cancer	0.00033	0.00127	CcSEcCtD
Lithium—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.00033	0.00127	CcSEcCtD
Lithium—Headache—Irinotecan—stomach cancer	0.000328	0.00127	CcSEcCtD
Lithium—Hypotension—Capecitabine—stomach cancer	0.000328	0.00127	CcSEcCtD
Lithium—Alopecia—Methotrexate—stomach cancer	0.000325	0.00125	CcSEcCtD
Lithium—Bradycardia—Doxorubicin—stomach cancer	0.000324	0.00125	CcSEcCtD
Lithium—Somnolence—Docetaxel—stomach cancer	0.000322	0.00124	CcSEcCtD
Lithium—Tinnitus—Epirubicin—stomach cancer	0.000321	0.00124	CcSEcCtD
Lithium—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.00032	0.00123	CcSEcCtD
Lithium—Vomiting—Fluorouracil—stomach cancer	0.000319	0.00123	CcSEcCtD
Lithium—Dyspepsia—Docetaxel—stomach cancer	0.000319	0.00123	CcSEcCtD
Lithium—Rash—Fluorouracil—stomach cancer	0.000317	0.00122	CcSEcCtD
Lithium—Dermatitis—Fluorouracil—stomach cancer	0.000316	0.00122	CcSEcCtD
Lithium—Decreased appetite—Docetaxel—stomach cancer	0.000315	0.00122	CcSEcCtD
Lithium—Headache—Fluorouracil—stomach cancer	0.000315	0.00121	CcSEcCtD
Lithium—Dysgeusia—Methotrexate—stomach cancer	0.000313	0.00121	CcSEcCtD
Lithium—Fatigue—Docetaxel—stomach cancer	0.000312	0.00121	CcSEcCtD
Lithium—Nausea—Irinotecan—stomach cancer	0.000311	0.0012	CcSEcCtD
Lithium—Dyspepsia—Capecitabine—stomach cancer	0.000309	0.00119	CcSEcCtD
Lithium—Arrhythmia—Epirubicin—stomach cancer	0.000307	0.00119	CcSEcCtD
Lithium—Decreased appetite—Capecitabine—stomach cancer	0.000305	0.00118	CcSEcCtD
Lithium—Alopecia—Epirubicin—stomach cancer	0.000304	0.00117	CcSEcCtD
Lithium—Fatigue—Capecitabine—stomach cancer	0.000302	0.00117	CcSEcCtD
Lithium—Vision blurred—Methotrexate—stomach cancer	0.000302	0.00116	CcSEcCtD
Lithium—Feeling abnormal—Docetaxel—stomach cancer	0.000299	0.00115	CcSEcCtD
Lithium—Nausea—Fluorouracil—stomach cancer	0.000298	0.00115	CcSEcCtD
Lithium—Tinnitus—Doxorubicin—stomach cancer	0.000297	0.00115	CcSEcCtD
Lithium—Gastrointestinal pain—Docetaxel—stomach cancer	0.000296	0.00114	CcSEcCtD
Lithium—Flatulence—Epirubicin—stomach cancer	0.000295	0.00114	CcSEcCtD
Lithium—Dysgeusia—Epirubicin—stomach cancer	0.000293	0.00113	CcSEcCtD
Lithium—Feeling abnormal—Capecitabine—stomach cancer	0.000289	0.00112	CcSEcCtD
Lithium—Vertigo—Methotrexate—stomach cancer	0.000288	0.00111	CcSEcCtD
Lithium—Gastrointestinal pain—Capecitabine—stomach cancer	0.000287	0.00111	CcSEcCtD
Lithium—Abdominal pain—Docetaxel—stomach cancer	0.000286	0.00111	CcSEcCtD
Lithium—Body temperature increased—Docetaxel—stomach cancer	0.000286	0.00111	CcSEcCtD
Lithium—Arrhythmia—Doxorubicin—stomach cancer	0.000284	0.0011	CcSEcCtD
Lithium—Vision blurred—Epirubicin—stomach cancer	0.000282	0.00109	CcSEcCtD
Lithium—Alopecia—Doxorubicin—stomach cancer	0.000281	0.00109	CcSEcCtD
Lithium—Abdominal pain—Capecitabine—stomach cancer	0.000277	0.00107	CcSEcCtD
Lithium—Body temperature increased—Capecitabine—stomach cancer	0.000277	0.00107	CcSEcCtD
Lithium—Convulsion—Methotrexate—stomach cancer	0.000277	0.00107	CcSEcCtD
Lithium—Agitation—Epirubicin—stomach cancer	0.000275	0.00106	CcSEcCtD
Lithium—Flatulence—Doxorubicin—stomach cancer	0.000273	0.00105	CcSEcCtD
Lithium—Arthralgia—Methotrexate—stomach cancer	0.000272	0.00105	CcSEcCtD
Lithium—Dysgeusia—Doxorubicin—stomach cancer	0.000271	0.00105	CcSEcCtD
Lithium—Discomfort—Methotrexate—stomach cancer	0.000269	0.00104	CcSEcCtD
Lithium—Vertigo—Epirubicin—stomach cancer	0.000269	0.00104	CcSEcCtD
Lithium—Syncope—Epirubicin—stomach cancer	0.000269	0.00104	CcSEcCtD
Lithium—Confusional state—Methotrexate—stomach cancer	0.000263	0.00102	CcSEcCtD
Lithium—Loss of consciousness—Epirubicin—stomach cancer	0.000263	0.00102	CcSEcCtD
Lithium—Vision blurred—Doxorubicin—stomach cancer	0.000261	0.00101	CcSEcCtD
Lithium—Asthenia—Docetaxel—stomach cancer	0.00026	0.001	CcSEcCtD
Lithium—Convulsion—Epirubicin—stomach cancer	0.000259	0.001	CcSEcCtD
Lithium—Arthralgia—Epirubicin—stomach cancer	0.000255	0.000984	CcSEcCtD
Lithium—Agitation—Doxorubicin—stomach cancer	0.000255	0.000983	CcSEcCtD
Lithium—Discomfort—Epirubicin—stomach cancer	0.000252	0.000972	CcSEcCtD
Lithium—Asthenia—Capecitabine—stomach cancer	0.000252	0.000972	CcSEcCtD
Lithium—Dry mouth—Epirubicin—stomach cancer	0.000249	0.000962	CcSEcCtD
Lithium—Vertigo—Doxorubicin—stomach cancer	0.000249	0.000961	CcSEcCtD
Lithium—Anorexia—Methotrexate—stomach cancer	0.000249	0.000961	CcSEcCtD
Lithium—Syncope—Doxorubicin—stomach cancer	0.000249	0.000959	CcSEcCtD
Lithium—Diarrhoea—Docetaxel—stomach cancer	0.000248	0.000957	CcSEcCtD
Lithium—Confusional state—Epirubicin—stomach cancer	0.000246	0.000951	CcSEcCtD
Lithium—Oedema—Epirubicin—stomach cancer	0.000244	0.000943	CcSEcCtD
Lithium—Hypotension—Methotrexate—stomach cancer	0.000244	0.000942	CcSEcCtD
Lithium—Loss of consciousness—Doxorubicin—stomach cancer	0.000244	0.00094	CcSEcCtD
Lithium—Shock—Epirubicin—stomach cancer	0.00024	0.000928	CcSEcCtD
Lithium—Convulsion—Doxorubicin—stomach cancer	0.00024	0.000927	CcSEcCtD
Lithium—Diarrhoea—Capecitabine—stomach cancer	0.00024	0.000926	CcSEcCtD
Lithium—Dizziness—Docetaxel—stomach cancer	0.00024	0.000925	CcSEcCtD
Lithium—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000238	0.000918	CcSEcCtD
Lithium—Arthralgia—Doxorubicin—stomach cancer	0.000236	0.000911	CcSEcCtD
Lithium—Discomfort—Doxorubicin—stomach cancer	0.000233	0.0009	CcSEcCtD
Lithium—Anorexia—Epirubicin—stomach cancer	0.000233	0.000899	CcSEcCtD
Lithium—Somnolence—Methotrexate—stomach cancer	0.000232	0.000896	CcSEcCtD
Lithium—Dizziness—Capecitabine—stomach cancer	0.000232	0.000895	CcSEcCtD
Lithium—Dry mouth—Doxorubicin—stomach cancer	0.000231	0.00089	CcSEcCtD
Lithium—Vomiting—Docetaxel—stomach cancer	0.00023	0.000889	CcSEcCtD
Lithium—Dyspepsia—Methotrexate—stomach cancer	0.00023	0.000887	CcSEcCtD
Lithium—Rash—Docetaxel—stomach cancer	0.000228	0.000882	CcSEcCtD
Lithium—Hypotension—Epirubicin—stomach cancer	0.000228	0.000881	CcSEcCtD
Lithium—Dermatitis—Docetaxel—stomach cancer	0.000228	0.000881	CcSEcCtD
Lithium—Confusional state—Doxorubicin—stomach cancer	0.000228	0.00088	CcSEcCtD
Lithium—Decreased appetite—Methotrexate—stomach cancer	0.000227	0.000876	CcSEcCtD
Lithium—Headache—Docetaxel—stomach cancer	0.000227	0.000876	CcSEcCtD
Lithium—Oedema—Doxorubicin—stomach cancer	0.000226	0.000873	CcSEcCtD
Lithium—Fatigue—Methotrexate—stomach cancer	0.000225	0.000869	CcSEcCtD
Lithium—Vomiting—Capecitabine—stomach cancer	0.000223	0.000861	CcSEcCtD
Lithium—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000223	0.000859	CcSEcCtD
Lithium—Shock—Doxorubicin—stomach cancer	0.000223	0.000859	CcSEcCtD
Lithium—Rash—Capecitabine—stomach cancer	0.000221	0.000854	CcSEcCtD
Lithium—Dermatitis—Capecitabine—stomach cancer	0.000221	0.000853	CcSEcCtD
Lithium—Headache—Capecitabine—stomach cancer	0.00022	0.000848	CcSEcCtD
Lithium—Somnolence—Epirubicin—stomach cancer	0.000217	0.000839	CcSEcCtD
Lithium—Anorexia—Doxorubicin—stomach cancer	0.000216	0.000832	CcSEcCtD
Lithium—Nausea—Docetaxel—stomach cancer	0.000215	0.000831	CcSEcCtD
Lithium—Feeling abnormal—Methotrexate—stomach cancer	0.000215	0.000831	CcSEcCtD
Lithium—Dyspepsia—Epirubicin—stomach cancer	0.000215	0.00083	CcSEcCtD
Lithium—Gastrointestinal pain—Methotrexate—stomach cancer	0.000214	0.000824	CcSEcCtD
Lithium—Decreased appetite—Epirubicin—stomach cancer	0.000212	0.00082	CcSEcCtD
Lithium—Hypotension—Doxorubicin—stomach cancer	0.000211	0.000816	CcSEcCtD
Lithium—Fatigue—Epirubicin—stomach cancer	0.000211	0.000813	CcSEcCtD
Lithium—Nausea—Capecitabine—stomach cancer	0.000208	0.000804	CcSEcCtD
Lithium—Abdominal pain—Methotrexate—stomach cancer	0.000206	0.000797	CcSEcCtD
Lithium—Body temperature increased—Methotrexate—stomach cancer	0.000206	0.000797	CcSEcCtD
Lithium—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000206	0.000795	CcSEcCtD
Lithium—Feeling abnormal—Epirubicin—stomach cancer	0.000201	0.000777	CcSEcCtD
Lithium—Somnolence—Doxorubicin—stomach cancer	0.000201	0.000776	CcSEcCtD
Lithium—Gastrointestinal pain—Epirubicin—stomach cancer	0.0002	0.000771	CcSEcCtD
Lithium—Dyspepsia—Doxorubicin—stomach cancer	0.000199	0.000768	CcSEcCtD
Lithium—Decreased appetite—Doxorubicin—stomach cancer	0.000197	0.000759	CcSEcCtD
Lithium—Fatigue—Doxorubicin—stomach cancer	0.000195	0.000753	CcSEcCtD
Lithium—Abdominal pain—Epirubicin—stomach cancer	0.000193	0.000746	CcSEcCtD
Lithium—Body temperature increased—Epirubicin—stomach cancer	0.000193	0.000746	CcSEcCtD
Lithium—Asthenia—Methotrexate—stomach cancer	0.000187	0.000723	CcSEcCtD
Lithium—Feeling abnormal—Doxorubicin—stomach cancer	0.000186	0.000719	CcSEcCtD
Lithium—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000185	0.000714	CcSEcCtD
Lithium—Abdominal pain—Doxorubicin—stomach cancer	0.000179	0.00069	CcSEcCtD
Lithium—Body temperature increased—Doxorubicin—stomach cancer	0.000179	0.00069	CcSEcCtD
Lithium—Diarrhoea—Methotrexate—stomach cancer	0.000179	0.00069	CcSEcCtD
Lithium—Asthenia—Epirubicin—stomach cancer	0.000175	0.000677	CcSEcCtD
Lithium—Dizziness—Methotrexate—stomach cancer	0.000173	0.000667	CcSEcCtD
Lithium—Diarrhoea—Epirubicin—stomach cancer	0.000167	0.000645	CcSEcCtD
Lithium—Vomiting—Methotrexate—stomach cancer	0.000166	0.000641	CcSEcCtD
Lithium—Rash—Methotrexate—stomach cancer	0.000165	0.000636	CcSEcCtD
Lithium—Dermatitis—Methotrexate—stomach cancer	0.000165	0.000635	CcSEcCtD
Lithium—Headache—Methotrexate—stomach cancer	0.000164	0.000631	CcSEcCtD
Lithium—Asthenia—Doxorubicin—stomach cancer	0.000162	0.000626	CcSEcCtD
Lithium—Dizziness—Epirubicin—stomach cancer	0.000162	0.000624	CcSEcCtD
Lithium—Vomiting—Epirubicin—stomach cancer	0.000155	0.0006	CcSEcCtD
Lithium—Nausea—Methotrexate—stomach cancer	0.000155	0.000599	CcSEcCtD
Lithium—Diarrhoea—Doxorubicin—stomach cancer	0.000155	0.000597	CcSEcCtD
Lithium—Rash—Epirubicin—stomach cancer	0.000154	0.000595	CcSEcCtD
Lithium—Dermatitis—Epirubicin—stomach cancer	0.000154	0.000594	CcSEcCtD
Lithium—Headache—Epirubicin—stomach cancer	0.000153	0.000591	CcSEcCtD
Lithium—Dizziness—Doxorubicin—stomach cancer	0.00015	0.000577	CcSEcCtD
Lithium—Nausea—Epirubicin—stomach cancer	0.000145	0.00056	CcSEcCtD
Lithium—Vomiting—Doxorubicin—stomach cancer	0.000144	0.000555	CcSEcCtD
Lithium—Rash—Doxorubicin—stomach cancer	0.000143	0.00055	CcSEcCtD
Lithium—Dermatitis—Doxorubicin—stomach cancer	0.000142	0.00055	CcSEcCtD
Lithium—Headache—Doxorubicin—stomach cancer	0.000142	0.000547	CcSEcCtD
Lithium—Nausea—Doxorubicin—stomach cancer	0.000134	0.000518	CcSEcCtD
Lithium—GSK3B—Developmental Biology—RHOA—stomach cancer	6.24e-05	0.000116	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—VEGFA—stomach cancer	6.23e-05	0.000116	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PRKAA1—stomach cancer	6.22e-05	0.000116	CbGpPWpGaD
Lithium—GSK3B—Disease—CD44—stomach cancer	6.2e-05	0.000116	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—MAPK1—stomach cancer	6.2e-05	0.000116	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—EGFR—stomach cancer	6.2e-05	0.000116	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—IL6—stomach cancer	6.19e-05	0.000116	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CDKN1B—stomach cancer	6.14e-05	0.000115	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CASP8—stomach cancer	6.12e-05	0.000114	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IL6R—stomach cancer	6.1e-05	0.000114	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—JUN—stomach cancer	6.08e-05	0.000114	CbGpPWpGaD
Lithium—GSK3A—Disease—ERCC2—stomach cancer	6.05e-05	0.000113	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RPS6—stomach cancer	6.02e-05	0.000112	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RBP4—stomach cancer	6.01e-05	0.000112	CbGpPWpGaD
Lithium—GSK3A—Disease—FGFR2—stomach cancer	5.91e-05	0.00011	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CDKN1A—stomach cancer	5.9e-05	0.00011	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—MAPK3—stomach cancer	5.89e-05	0.00011	CbGpPWpGaD
Lithium—GSK3A—Immune System—IRS2—stomach cancer	5.86e-05	0.000109	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—KRAS—stomach cancer	5.85e-05	0.000109	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—MYC—stomach cancer	5.83e-05	0.000109	CbGpPWpGaD
Lithium—GSK3B—Disease—HBEGF—stomach cancer	5.83e-05	0.000109	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CDH1—stomach cancer	5.8e-05	0.000108	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—ERBB2—stomach cancer	5.77e-05	0.000108	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—MAPK8—stomach cancer	5.76e-05	0.000107	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—CXCL8—stomach cancer	5.72e-05	0.000107	CbGpPWpGaD
Lithium—GSK3B—Immune System—PPP2R1A—stomach cancer	5.71e-05	0.000107	CbGpPWpGaD
Lithium—GSK3A—Disease—MTHFR—stomach cancer	5.69e-05	0.000106	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CDKN1A—stomach cancer	5.66e-05	0.000106	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—MAPK1—stomach cancer	5.61e-05	0.000105	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—EGFR—stomach cancer	5.61e-05	0.000105	CbGpPWpGaD
Lithium—IMPA2—Metabolism—PIK3CA—stomach cancer	5.57e-05	0.000104	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—TP53—stomach cancer	5.55e-05	0.000104	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HBEGF—stomach cancer	5.53e-05	0.000103	CbGpPWpGaD
Lithium—GSK3A—Disease—IRS2—stomach cancer	5.41e-05	0.000101	CbGpPWpGaD
Lithium—GSK3A—Immune System—PRKCB—stomach cancer	5.41e-05	0.000101	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6ST—stomach cancer	5.39e-05	0.000101	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—PIK3CA—stomach cancer	5.38e-05	0.0001	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—KRAS—stomach cancer	5.3e-05	9.89e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PPP2R1A—stomach cancer	5.28e-05	9.85e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—CAV1—stomach cancer	5.25e-05	9.79e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—APOA1—stomach cancer	5.23e-05	9.77e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HSPB1—stomach cancer	5.17e-05	9.65e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AGTR2—stomach cancer	5.17e-05	9.65e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—F2R—stomach cancer	5.11e-05	9.54e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—BMP2—stomach cancer	5.11e-05	9.54e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ADRB2—stomach cancer	5.1e-05	9.53e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—ERBB2—stomach cancer	5.1e-05	9.52e-05	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—IL6—stomach cancer	5.08e-05	9.48e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—FYN—stomach cancer	5.04e-05	9.41e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—MAPK3—stomach cancer	5.03e-05	9.39e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AKR1C3—stomach cancer	5.03e-05	9.39e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PPP2R1A—stomach cancer	5e-05	9.33e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—HRAS—stomach cancer	4.98e-05	9.29e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR1A—stomach cancer	4.97e-05	9.29e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6ST—stomach cancer	4.97e-05	9.29e-05	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PIK3CA—stomach cancer	4.97e-05	9.27e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—MMP9—stomach cancer	4.95e-05	9.25e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—SMAD4—stomach cancer	4.9e-05	9.15e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—ERBB2—stomach cancer	4.9e-05	9.14e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—CASP8—stomach cancer	4.82e-05	9e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6R—stomach cancer	4.81e-05	8.97e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ANXA1—stomach cancer	4.8e-05	8.97e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—MAPK1—stomach cancer	4.78e-05	8.93e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—EGFR—stomach cancer	4.78e-05	8.93e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—APC—stomach cancer	4.78e-05	8.92e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—CDH1—stomach cancer	4.76e-05	8.89e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—IL6—stomach cancer	4.76e-05	8.89e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGFR2—stomach cancer	4.73e-05	8.83e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CDKN1B—stomach cancer	4.72e-05	8.82e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADRB1—stomach cancer	4.65e-05	8.69e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—FYN—stomach cancer	4.65e-05	8.68e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SMAD4—stomach cancer	4.64e-05	8.67e-05	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—EGFR—stomach cancer	4.59e-05	8.57e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CDKN1B—stomach cancer	4.53e-05	8.47e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—KRAS—stomach cancer	4.52e-05	8.44e-05	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—HRAS—stomach cancer	4.5e-05	8.41e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—JUN—stomach cancer	4.5e-05	8.39e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—ERCC2—stomach cancer	4.47e-05	8.35e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—VEGFA—stomach cancer	4.45e-05	8.3e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RPS6—stomach cancer	4.45e-05	8.3e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6R—stomach cancer	4.44e-05	8.28e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FYN—stomach cancer	4.41e-05	8.23e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—STAT3—stomach cancer	4.4e-05	8.22e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—FGFR2—stomach cancer	4.37e-05	8.15e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CDKN1A—stomach cancer	4.36e-05	8.14e-05	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—KRAS—stomach cancer	4.34e-05	8.1e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IRS2—stomach cancer	4.33e-05	8.09e-05	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—IL6—stomach cancer	4.31e-05	8.05e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—MAPK8—stomach cancer	4.25e-05	7.94e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—MAPK3—stomach cancer	4.21e-05	7.85e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—MTHFR—stomach cancer	4.2e-05	7.85e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CDKN1A—stomach cancer	4.18e-05	7.81e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—SERPINE1—stomach cancer	4.16e-05	7.76e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—PIK3CA—stomach cancer	4.15e-05	7.75e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGFR2—stomach cancer	4.14e-05	7.73e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HBEGF—stomach cancer	4.09e-05	7.63e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—ERBB2—stomach cancer	4.02e-05	7.5e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—RHOA—stomach cancer	4.01e-05	7.48e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—MAPK1—stomach cancer	4e-05	7.47e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—EGFR—stomach cancer	4e-05	7.47e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—IRS2—stomach cancer	4e-05	7.46e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—PRKCB—stomach cancer	4e-05	7.46e-05	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—PIK3CA—stomach cancer	3.99e-05	7.44e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6ST—stomach cancer	3.98e-05	7.43e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—NOS3—stomach cancer	3.97e-05	7.41e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—CAV1—stomach cancer	3.88e-05	7.24e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—APOA1—stomach cancer	3.87e-05	7.22e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—HRAS—stomach cancer	3.84e-05	7.17e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TNF—stomach cancer	3.81e-05	7.12e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IRS2—stomach cancer	3.79e-05	7.07e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—KRAS—stomach cancer	3.78e-05	7.06e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADRB2—stomach cancer	3.77e-05	7.04e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—CDKN1B—stomach cancer	3.72e-05	6.95e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—MAPK3—stomach cancer	3.72e-05	6.94e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—ERBB2—stomach cancer	3.71e-05	6.93e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PPP2R1A—stomach cancer	3.69e-05	6.9e-05	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—HRAS—stomach cancer	3.69e-05	6.89e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IL6—stomach cancer	3.68e-05	6.86e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6ST—stomach cancer	3.68e-05	6.86e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CAV1—stomach cancer	3.67e-05	6.86e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APOA1—stomach cancer	3.67e-05	6.84e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL1B—stomach cancer	3.66e-05	6.83e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—PTGS2—stomach cancer	3.63e-05	6.77e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—CASP8—stomach cancer	3.56e-05	6.65e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6R—stomach cancer	3.55e-05	6.63e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—JUN—stomach cancer	3.54e-05	6.62e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—MAPK1—stomach cancer	3.53e-05	6.6e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—EGFR—stomach cancer	3.53e-05	6.6e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—APC—stomach cancer	3.53e-05	6.59e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—CDH1—stomach cancer	3.52e-05	6.57e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PRKCB—stomach cancer	3.5e-05	6.53e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6ST—stomach cancer	3.48e-05	6.5e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—CDKN1B—stomach cancer	3.44e-05	6.42e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—CDKN1A—stomach cancer	3.43e-05	6.41e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SMAD4—stomach cancer	3.43e-05	6.4e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—EGFR—stomach cancer	3.39e-05	6.34e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—MAPK8—stomach cancer	3.35e-05	6.26e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APC—stomach cancer	3.35e-05	6.25e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—KRAS—stomach cancer	3.34e-05	6.23e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6R—stomach cancer	3.28e-05	6.12e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FYN—stomach cancer	3.26e-05	6.08e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—HRAS—stomach cancer	3.21e-05	6e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—KRAS—stomach cancer	3.21e-05	5.99e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—CDKN1A—stomach cancer	3.17e-05	5.92e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6R—stomach cancer	3.11e-05	5.8e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—IL6—stomach cancer	3.08e-05	5.74e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—SERPINE1—stomach cancer	3.07e-05	5.73e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—PIK3CA—stomach cancer	3.07e-05	5.73e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—STAT3—stomach cancer	3.07e-05	5.72e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGFR2—stomach cancer	3.06e-05	5.71e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—ERBB2—stomach cancer	2.97e-05	5.54e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—RHOA—stomach cancer	2.96e-05	5.53e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—PIK3CA—stomach cancer	2.95e-05	5.5e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—NOS3—stomach cancer	2.93e-05	5.47e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—MAPK3—stomach cancer	2.93e-05	5.47e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SERPINE1—stomach cancer	2.91e-05	5.43e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—HRAS—stomach cancer	2.84e-05	5.3e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—STAT3—stomach cancer	2.83e-05	5.28e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RHOA—stomach cancer	2.81e-05	5.24e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IRS2—stomach cancer	2.8e-05	5.23e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—MAPK1—stomach cancer	2.79e-05	5.2e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—EGFR—stomach cancer	2.79e-05	5.2e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NOS3—stomach cancer	2.78e-05	5.19e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—CDKN1B—stomach cancer	2.75e-05	5.13e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—ERBB2—stomach cancer	2.74e-05	5.12e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HRAS—stomach cancer	2.73e-05	5.09e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IL6—stomach cancer	2.72e-05	5.07e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CAV1—stomach cancer	2.71e-05	5.07e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOA1—stomach cancer	2.71e-05	5.06e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—MAPK3—stomach cancer	2.7e-05	5.05e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL1B—stomach cancer	2.7e-05	5.04e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PTGS2—stomach cancer	2.68e-05	5.01e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—KRAS—stomach cancer	2.63e-05	4.91e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—MYC—stomach cancer	2.63e-05	4.91e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—JUN—stomach cancer	2.62e-05	4.89e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ERBB2—stomach cancer	2.6e-05	4.85e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PRKCB—stomach cancer	2.58e-05	4.82e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6ST—stomach cancer	2.57e-05	4.8e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—MAPK1—stomach cancer	2.57e-05	4.8e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—EGFR—stomach cancer	2.57e-05	4.8e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—CDKN1B—stomach cancer	2.54e-05	4.74e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—CDKN1A—stomach cancer	2.54e-05	4.74e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—MAPK8—stomach cancer	2.48e-05	4.63e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APC—stomach cancer	2.47e-05	4.62e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CXCL8—stomach cancer	2.46e-05	4.6e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—KRAS—stomach cancer	2.43e-05	4.54e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—PIK3CA—stomach cancer	2.42e-05	4.51e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CDKN1B—stomach cancer	2.41e-05	4.49e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—CDKN1A—stomach cancer	2.34e-05	4.38e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6R—stomach cancer	2.3e-05	4.29e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCND1—stomach cancer	2.3e-05	4.29e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—JUN—stomach cancer	2.29e-05	4.28e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—STAT3—stomach cancer	2.26e-05	4.23e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—HRAS—stomach cancer	2.24e-05	4.18e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—PIK3CA—stomach cancer	2.23e-05	4.17e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MMP9—stomach cancer	2.23e-05	4.16e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CDKN1A—stomach cancer	2.22e-05	4.15e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MAPK8—stomach cancer	2.17e-05	4.05e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—MAPK3—stomach cancer	2.16e-05	4.04e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SERPINE1—stomach cancer	2.15e-05	4.01e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6—stomach cancer	2.14e-05	4e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—STAT3—stomach cancer	2.09e-05	3.9e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RHOA—stomach cancer	2.07e-05	3.87e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—HRAS—stomach cancer	2.07e-05	3.86e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—MAPK1—stomach cancer	2.06e-05	3.84e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—EGFR—stomach cancer	2.06e-05	3.84e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NOS3—stomach cancer	2.05e-05	3.83e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—VEGFA—stomach cancer	2e-05	3.74e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—MAPK3—stomach cancer	2e-05	3.73e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—STAT3—stomach cancer	1.98e-05	3.7e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6—stomach cancer	1.98e-05	3.69e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—KRAS—stomach cancer	1.94e-05	3.63e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—MYC—stomach cancer	1.94e-05	3.63e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ERBB2—stomach cancer	1.92e-05	3.58e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—MAPK1—stomach cancer	1.9e-05	3.55e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—EGFR—stomach cancer	1.9e-05	3.55e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MAPK3—stomach cancer	1.89e-05	3.53e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MYC—stomach cancer	1.84e-05	3.44e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCL8—stomach cancer	1.82e-05	3.4e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MAPK1—stomach cancer	1.8e-05	3.36e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—EGFR—stomach cancer	1.8e-05	3.36e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—KRAS—stomach cancer	1.8e-05	3.35e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—PIK3CA—stomach cancer	1.79e-05	3.34e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CDKN1B—stomach cancer	1.78e-05	3.32e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—KRAS—stomach cancer	1.7e-05	3.18e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCND1—stomach cancer	1.7e-05	3.17e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—JUN—stomach cancer	1.69e-05	3.16e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—HRAS—stomach cancer	1.65e-05	3.09e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PIK3CA—stomach cancer	1.65e-05	3.08e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MMP9—stomach cancer	1.65e-05	3.07e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CDKN1A—stomach cancer	1.64e-05	3.06e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MAPK8—stomach cancer	1.6e-05	2.99e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6—stomach cancer	1.58e-05	2.95e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PIK3CA—stomach cancer	1.56e-05	2.92e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—HRAS—stomach cancer	1.53e-05	2.85e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TP53—stomach cancer	1.51e-05	2.82e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—VEGFA—stomach cancer	1.48e-05	2.76e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—STAT3—stomach cancer	1.46e-05	2.73e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6—stomach cancer	1.46e-05	2.73e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HRAS—stomach cancer	1.45e-05	2.7e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MAPK3—stomach cancer	1.4e-05	2.61e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6—stomach cancer	1.38e-05	2.58e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MYC—stomach cancer	1.36e-05	2.54e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MAPK1—stomach cancer	1.33e-05	2.49e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—EGFR—stomach cancer	1.33e-05	2.48e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—KRAS—stomach cancer	1.26e-05	2.35e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PIK3CA—stomach cancer	1.16e-05	2.16e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TP53—stomach cancer	1.12e-05	2.09e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HRAS—stomach cancer	1.07e-05	2e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6—stomach cancer	1.02e-05	1.91e-05	CbGpPWpGaD
